The store will not work correctly when cookies are disabled.
cyano-3-(5-phenoxypentyl)(pyridin-4-yl)guanidine
ID: ALA322225
PubChem CID: 18365476
Max Phase: Preclinical
Molecular Formula: C18H21N5O
Molecular Weight: 323.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#CN(C(=N)NCCCCCOc1ccccc1)c1ccncc1
Standard InChI: InChI=1S/C18H21N5O/c19-15-23(16-9-12-21-13-10-16)18(20)22-11-5-2-6-14-24-17-7-3-1-4-8-17/h1,3-4,7-10,12-13H,2,5-6,11,14H2,(H2,20,22)
Standard InChI Key: FJZCMMCVSNUIEO-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
3.5542 -1.3125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3792 -1.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1417 -2.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -2.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7917 -2.0292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1417 -0.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3167 0.8333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7917 -0.5917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3167 -0.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5542 0.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3292 -2.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5042 -2.7417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9042 0.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1417 0.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6167 -0.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0917 -2.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7417 -2.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7417 -3.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0292 -1.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2667 -2.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8542 -1.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5667 -3.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5667 -2.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9792 -2.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 3 0
5 2 2 0
6 1 1 0
7 14 1 0
8 2 1 0
9 6 2 0
10 6 1 0
11 12 1 0
12 16 1 0
13 9 1 0
14 10 2 0
15 8 1 0
16 20 1 0
17 11 1 0
18 11 2 0
19 15 1 0
20 21 1 0
21 19 1 0
22 18 1 0
23 17 2 0
24 22 2 0
7 13 2 0
24 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 323.40 | Molecular Weight (Monoisotopic): 323.1746 | AlogP: 3.14 | #Rotatable Bonds: 8 |
Polar Surface Area: 85.03 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.40 | CX LogP: 2.82 | CX LogD: 2.82 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.26 | Np Likeness Score: -0.61 |
References
1. Schou C, Ottosen ER, Petersen HJ, Bjorkling F, Latini S, Hjarnaa PV, Bramm E, Binderup L. (1997) Novel cyanoguanidines with potent oral antitumour activity, 7 (24): [10.1016/S0960-894X(97)10152-4] |